Related Experiment Video
Updated: Jan 24, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Cystic fibrosis year in review 2018, part 1
Adrienne P Savant1,2,3, Susanna A McColley1,2,3
1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Insights
In 2018, cystic fibrosis research focused on CFTR modulator therapies, inflammation, infection, and disease assessment. This summary highlights key findings and case reports from the year.
Area of Science:
- Pulmonology
- Genetics
- Medical Research
Background:
- Cystic fibrosis (CF) is a genetic disorder affecting multiple organs.
- Significant advancements in understanding CF pathophysiology and treatment were made.
- 2018 saw a surge in research, particularly concerning novel therapeutic approaches.
Purpose of the Study:
- To provide a comprehensive overview of 2018 cystic fibrosis research.
- To summarize key findings in CFTR modulator therapies.
- To report on advancements in understanding inflammation, infection, and disease progression.
Main Methods:
- Literature review of 2018 publications on cystic fibrosis.
- Analysis of case reports and clinical trial outcomes.
- Synthesis of data on epidemiology, physiology, and imaging.
Main Results:
- CFTR modulator therapies showed promising results in clinical studies.
- Research elucidated the complex interplay of inflammation and infection in CF.
- Epidemiologic data and advanced imaging techniques refined disease assessment.
Conclusions:
- 2018 was a pivotal year for cystic fibrosis research, especially regarding modulator therapies.
- Continued investigation into inflammation, infection, and disease progression is crucial.
- Integrated approaches combining therapeutics and monitoring are advancing patient care.
Abstract:
Cystic fibrosis research and case reports were robust in the year 2018. This report summarizes research and cases related to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator therapies, inflammation and infection, epidemiology and the physiologic, and imaging assessment of disease.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
SN1 Reaction: Stereochemistry
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
SN1 Reaction: Kinetics
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...

